All iPSCs were cultured as described previously (Roberts et al., 2017 (link)). Untagged iPSCs (Coriell Institute for Medical Research; GM25256) and mEGFP-tagged LMNB1 iPSCs (Allen Institute for Cell Science, Coriell; AICS-0013 cl.210) were grown in mTeSR and mTeSR Plus in cell culture dishes coated with Matrigel matrix (Growth Factor Reduced; Corning; 354230, or phenol-red-free; Corning; 356237). Matrigel was applied at a concentration of 137–154 µg/ml dissolved in PBS or DMEM. Cells were dissociated using Gentle Cell Dissociation Reagent (Stem Cell Technologies; 100-0485) or Versene Solution (Thermofisher Scientific; 15040066) and ROCK Inhibitor Y27632 at a final concentration of 10 µM (ATCC; ACS-3030). iPSCs were differentiated using STEMdiff Trilineage Differentiation Kit (Stem Cell Technologies; 05230) or STEMdiff Mesoderm Induction Medium (Stem Cell Technologies; 05220). All cells were maintained at 37°C at 5% CO2. Pluripotency and differentiation were confirmed using Oct4, Nanog, HNF-3β, Otx-2, and Brachyury antibodies in immunofluorescence assays.